WACO’S BRIAN PARDO has given a lot of thought to being on what he calls “the leading edge.” The fifty-year-old entrepreneur has recently started a business, Life Partners, that some people see as pushing the limits way too far: Pardo represents clients who want to buy life insurance policies held by terminally ill people, mostly people with AIDS. “I have been accused of speculating in death,” he says, “but there is no speculation to this. These people are terminally ill and are going to die. All we are trying to do is provide them with financial assistance.
Buying up insurance benefits is nothing new, although in the past it hasn’t been common. The practice, usually arranged privately among family members, has been around since the beginning of the insurance industry three hundred years ago. The AIDS epidemic has mad it common. With more than seventy licensed offices all over the country, Life Partners, founded in 1991, is the largest company specializing in this new market. But it is the kind of business that makes people uneasy, and Pardo is the focus of a controversy over the morality and legality of this enterprise.
Pardo doesn’t advertise—although companies similar to his place ads in gay-oriented publications. He says that all of his clients arrange to sell their policies through their lawyers or financial planners. “At this point the AIDS victims are desperate,” says Pardo. “Their income has stopped, their health insurance has run out, and they can’t make their house payments, much less the monthly premium on their life insurance policy.” Pardo helps solve all those problems. For a 3 to 5 percent fee, Pardo explains, his company acts as a clearinghouse for buyers, who purchase the policy for 80 to 85 percent of its face value in exchange for being named the policy owner. The seller is responsible for legal fees and closing costs, so the seller ends up with 65 to 70 percent of the policy’s coverage value. Once the transaction is completed, the money is wired into the seller’s bank account. The new owner collects at 100 percent when the seller dies. Says Pardo: “It’s a win-win situation for everybody.” Pardo’s clients seem to agree. The companion of one AIDS victim who sold his policy to Life Partners in June says, “There is a definite need for it—it gave my friend peace of mind.
Pardo’s modest suite is on a street lined with insurance companies and industrial offices. On his desk is a photo of Pardo and President Jimmy Carter taken in the White House Cabinet Room when Pardo served on Carter’s ad hoc committee on alternative energy. Behind the desk hang pictures of Pardo’s two daughters and an autographed photo of Ronald Reagan. In vigorous middle age, Pardo hardly looks like a scavenger profiting from the misfortunes of the terminally ill, as some have painted him.
North Dakota securities commissioner Glenn Pomeroy labeled Life Partners “ghoulish, insensitive…and flat-out illegal” and called a press conference at Washingon’s National Press Club last August to say so. Pomeroy learned about Life Partners from a letter that one of Pardo’s licensees in Florida had written to a friend in North Dakota in which the licensee claimed that one can “make big bucks” buying policies. Pardo agrees that the remarks were unfortunate. “They were also true,” he says. Pomeroy heard about the letter and hastily issued a cease and desist order to prevent Pardo from conducting business in North Dakota. Pardo is countersuing Pomeroy and the North American Securities Administrators Association for slander and libel.
But the bad publicity hasn’t kept clients away. Says one Waco investor: “It’s hard to resist an opportunity to do some good and get a superior return on your investment too.” And with certificates of deposit offering 2.5 percent, the return on a Life Parners investment is appealing—25 percent or more in a year is possible. There are risks, Pardo warns. A cure for AIDS could be discovered, or the patient could live longer than 24 months. And the potential for legal entanglements is great. Although this burgeoning industry is not yet regulated, legislation is being discussed that would require licenses both for individuals who sell their own policies and for clients who buy the policies. Other regulations would establish prices and rates of return. But as with any other investment, obvious variables—in this case, the patient’s health and life expectancy—are meticulously calculated.
Confidential medical histories of people